{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T23:02:25Z","timestamp":1768345345795,"version":"3.49.0"},"update-to":[{"DOI":"10.1002\/14651858.cd009396","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T00:00:00Z","timestamp":1404777600000}}],"reference-count":82,"publisher":"Wiley","issue":"7","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd009396.pub2","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T17:08:15Z","timestamp":1404839295000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trifluoperazine versus low-potency first-generation antipsychotic drugs for schizophrenia"],"prefix":"10.1002","volume":"2014","author":[{"given":"Magdolna","family":"Tardy","sequence":"first","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Dold","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen Klinikum rechts der Isar; Klinik und Poliklinik f\u00fcr Psychiatrie und Psychotherapie; M\u00f6hlstr. 26 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf R","family":"Engel","sequence":"additional","affiliation":[{"name":"Ludwig-Maximilians-University Munich; Psychiatric Hospital; Nussbaumstr. 7 Muenchen Germany 80336"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Leucht","sequence":"additional","affiliation":[{"name":"Technische Universit\u00e4t M\u00fcnchen; Department of Psychiatry and Psychotherapy; Ismaningerstrasse 22 M\u00fcnchen Germany 81675"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2014,7,8]]},"reference":[{"issue":"4","key":"10.1002\/14651858.CD009396.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1177\/070674376200700403","article-title":"Chlorpromazine, trifluoperazine and placebo with long-term mental hospital patients","volume":"7","author":"Coons","year":"1962","journal-title":"Canadian Psychiatric Association Journal"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0002|cit2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF00403632","article-title":"The comparative effectiveness of eight phenthiazines","volume":"7","author":"Hanlon","year":"1965","journal-title":"Psychopharmacologia"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0003|cit3","first-page":"15","article-title":"Trifluoperazine in chronic psychiatric patients","volume":"21","author":"Hollister","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1192\/bjp.123.6.659","article-title":"Life events and maintenance therapy in schizophrenic relapse","volume":"123","author":"Leff","year":"1973","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1136\/bmj.3.5775.599","article-title":"Trial of maintenance therapy in schizophrenia","volume":"3","author":"Leff","year":"1971","journal-title":"British Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD009396.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/ajp.124.11.1585","article-title":"A study of the withdrawal of chlorpromazine or trifluoperazine in chronic schizophrenia","volume":"124","author":"Morton","year":"1968","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0007|cit7","first-page":"265","article-title":"Acute paranoid schizophrenia (treatment with chlorpromazine, trifluoperazine and placebo)","volume":"27","author":"Reardon","year":"1966","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0008|cit8","first-page":"151","article-title":"A comparison of thioridazine, trifluoperazine, chlorpromazine, and placebo: a double-blind controlled study on the treatment of chronic hospitalized, schizophrenic patients","volume":"22","author":"Schiele","year":"1961","journal-title":"Journal of Clinical and Experimental Psychopathology"},{"issue":"9","key":"10.1002\/14651858.CD009396.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1176\/ajp.115.9.812","article-title":"Trifluoperazine in the treatment of chronic schizophrenics","volume":"115","author":"Barsa","year":"1959","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1176\/ajp.117.11.997","article-title":"Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine","volume":"117","author":"Casey","year":"1961","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1176\/ajp.118.6.552","article-title":"A comparison of the effectiveness of trifluoperazine and chlorpromazine in schizophrenia","volume":"118","author":"Childers","year":"1964","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009396.pub2-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1001\/archneur.1970.00480200082009","article-title":"High doses of trifluperazine and tardive dyskinesia","volume":"22","author":"Crane","year":"1970","journal-title":"Archives of Neurology"},{"issue":"11","key":"10.1002\/14651858.CD009396.pub2-BIB0013|cit13","first-page":"702","article-title":"Efficacy of phenothiazines without antiparkinson drugs","volume":"26","author":"Jong","year":"1965","journal-title":"Diseases of the Nervous System"},{"issue":"3","key":"10.1002\/14651858.CD009396.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S0033-3182(71)71533-3","article-title":"Prolixin enanthate and thorazine-stelazine regimens in the treatment of schizophrenic patients. An experimental evaluation","volume":"12","author":"DeWolfe","year":"1971","journal-title":"Psychosomatics"},{"issue":"1","key":"10.1002\/14651858.CD009396.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1600-0447.1992.tb01446.x","article-title":"Effects of antipsychotic drugs on memory functions of schizophrenic patients","volume":"85","author":"Eitan","year":"1992","journal-title":"Acta Psychiatrica Scandinavica"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1176\/ajp.115.7.577","article-title":"Therapeutic implications of differential effects of new phenothiazine compounds","volume":"116","author":"Freyhan","year":"1959","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009396.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0033-3182(70)71685-X","article-title":"Thiothixene and trifluoperazine in a step system","volume":"11","author":"Gardos","year":"1970","journal-title":"Psychosomatics"},{"issue":"2","key":"10.1002\/14651858.CD009396.pub2-BIB0018|cit18","first-page":"224","article-title":"The effects of selected antipsychotic drugs of human judgment","volume":"21","author":"Gillis","year":"1977","journal-title":"Current Therapeutic Research, Clinical and Experimental"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1192\/bjp.109.461.510","article-title":"A controlled trial on the value of prochlorperazine, trifluoperazine and intensive group treatment","volume":"109","author":"Hamilton","year":"1963","journal-title":"British Journal of Psychiatry"},{"issue":"554","key":"10.1002\/14651858.CD009396.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1192\/bjp.120.554.41","article-title":"Persistence of extra-pyramidal disorders and psychiatric relapse after withdrawal of long-term phenothiazine therapy","volume":"120","author":"Hershon","year":"1972","journal-title":"British Journal of Psychiatry"},{"issue":"552","key":"10.1002\/14651858.CD009396.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1192\/bjp.119.552.545","article-title":"Effects of chlorpromazine and trifluoperazine on the activity of chronic schizophrenics","volume":"119","author":"Jones","year":"1971","journal-title":"British Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009396.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/070674376601100106","article-title":"A comparison of two butyrophenones with trifluoperazine","volume":"11","author":"Marjerrison","year":"1966","journal-title":"Canadian Psychiatric Association Journal"},{"issue":"9","key":"10.1002\/14651858.CD009396.pub2-BIB0023|cit23","first-page":"601","article-title":"Selective drug action related to chronic schizophrenic subtype (A comparative study of carphenazine, chlorpromazine, and trifluoperazine)","volume":"28","author":"Platz","year":"1967","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0024|cit24","unstructured":"Prien RF Levine J Cole JO High dose therapy in chronic schizophrenia - trifuoperazine Proceedings of the 121st Annual Meeting of the American Psychiatric Association; 1968 May 13-17; Boston, Massachusetts, USA 1968"},{"issue":"3","key":"10.1002\/14651858.CD009396.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1176\/ajp.126.3.305","article-title":"High dose trifluoperazine therapy in chronic schizophrenia","volume":"126","author":"Prien","year":"1969","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1176\/ajp.115.4.364","article-title":"Trifluoperazine in the treatment of psychotic patients","volume":"115","author":"Rudy","year":"1958","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1176\/ajp.115.3.253","article-title":"A comparison of triflupromazine (vesprin), chlorpromazine and PLACEBO in 85 chronic patients","volume":"115","author":"Smith","year":"1958","journal-title":"American Journal of Psychiatry"},{"issue":"2","key":"10.1002\/14651858.CD009396.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1097\/00005053-196702000-00004","article-title":"The effects of carphenazine, trifluoperazine and chlorpromazine on ward behavior, physiological functioning and psychological test scores in chronic schizophrenic patients","volume":"144","author":"Spiegel","year":"1967","journal-title":"Journal of Nervous and Mental Diseases"},{"issue":"4","key":"10.1002\/14651858.CD009396.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/00048677509159857","article-title":"Tranquilizers or anti-depressants for chronic schizophrenics: a long term study","volume":"9","author":"Teja","year":"1975","journal-title":"Australian and New Zealand Journal of Psychiatry"},{"issue":"1","key":"10.1002\/14651858.CD009396.pub2-BIB0030|cit30","first-page":"24","article-title":"Comparison of influence of perazine, fluphenazine, trifluoroperazine, chloropromazine and haloperidol on primary and deficit schizophrenic symptoms in patients first hospitalized because of paranoid schizophrenia","volume":"23","author":"Terminska","year":"1989","journal-title":"Psychiatria Polska"},{"issue":"12","key":"10.1002\/14651858.CD009396.pub2-BIB0031|cit31","first-page":"821","article-title":"Differential drug effects of two phenothiazines (A controlled comparison of thioridazine and trifluoperazine in chronic schizophrenics)","volume":"31","author":"Vestre","year":"1970","journal-title":"Diseases of the Nervous System"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0032|cit32","first-page":"447","article-title":"Clinical experience with trifluoperazine","volume":"8","author":"Vinar","year":"1968","journal-title":"Activitas Nervosa Superior"},{"issue":"2","key":"10.1002\/14651858.CD009396.pub2-BIB0033|cit33","first-page":"113","article-title":"Differences in the clinical effect of various neuroleptics","volume":"14","author":"Welbel","year":"1980","journal-title":"Psychiatria Polska"},{"issue":"1","key":"10.1002\/14651858.CD009396.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"776","DOI":"10.5694\/j.1326-5377.1961.tb69141.x","article-title":"A terminal double-blind trial of tri-fluoperazine (\"stelazine\") in chronic schizophrenia","volume":"48","author":"Weston","year":"1961","journal-title":"Medical Journal of Australia"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1192\/bjp.107.446.90","article-title":"A double-blind trial to investigate the effects of thorazine (largactil, chlorpromazine), compazine (stemetil, prochlorperazine) and stelazine (trifluoperazine) in paranoid schizophrenia","volume":"107","author":"Wilson","year":"1961","journal-title":"Journal of Mental Science"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"Andreasen","year":"2010","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0038|cit38","volume-title":"Psychische Erkrankungen. Klinik und Therapie","author":"Berger","year":"2003"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1136\/bmj.315.7108.600","article-title":"Statistics notes. Trials randomised in clusters","volume":"315","author":"Bland","year":"1997","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD009396.pub2-BIB0040|cit40","first-page":"405","article-title":"The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use","volume":"54","author":"Boissel","year":"1999","journal-title":"Therapie"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1177\/135581960000500105","article-title":"Sample size calculations for cluster randomised trials. Changing Professional Practice in Europe Group (EU BIOMED II Concerted Action)","volume":"5","author":"Campbell","year":"2000","journal-title":"Journal of Health Services Research and Policy"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1056\/NEJM199403103301006","article-title":"Schizophrenia","volume":"330","author":"Carpenter","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"12","key":"10.1002\/14651858.CD009396.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1176\/ajp.132.12.1237","article-title":"Overview: maintenance therapy in psychiatry: I. Schizophrenia","volume":"132","author":"Davis","year":"1975","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0044|cit44","article-title":"Antipsychotic drugs","volume-title":"Comprehensive Textbook of Psychiatry","author":"Davis","year":"1989"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0045|cit45","unstructured":"Deeks J Issues in the selection for meta-analyses of binary data Proceedings of the 8th International Cochrane Colloquium; 2000 Oct 25-28th; Cape Town, South Africa Cape Town 2000"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"Der-Simonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0047|cit47","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/BF02599201","article-title":"The unit of analysis error in studies about physicians' patient care behavior","volume":"7","author":"Divine","year":"1992","journal-title":"Journal of General Internal Medicine"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"13","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1093\/ije\/31.1.140","article-title":"Meta-analyses involving cross-over trials: methodological issues","volume":"31","author":"Elbourne","year":"2002","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/15622970510030090","article-title":"World Federation of Societies of Biological Psychiatry (WFSBP) - Guidelines for biological treatment of schizophrenia, part 1: Acute treatment of schizophrenia","volume":"6","author":"Falkai","year":"2005","journal-title":"World Journal of Biololgical Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.schres.2010.10.016","article-title":"Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials","volume":"126","author":"Furukawa","year":"2011","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0052|cit52","volume-title":"Behandlungsleitlinie Schizophrenie","author":"Gaebel","year":"2006"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1093\/oxfordjournals.aje.a009904","article-title":"Components of variance and intraclass correlations for the design of community-based surveys and intervention studies: data from the Health Survey for England 1994","volume":"149","author":"Gulliford","year":"1999","journal-title":"American Journal of Epidemiology"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0054|cit54","volume-title":"Dosierung der Neuroleptika. Ein Leitfaden f\u00fcr Klinik und Praxis unter besonderer Ber\u00fccksichtigung psychotisch Kranker","author":"Haase","year":"1983"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00223980.1940.9917000","article-title":"A multiphasic personality schedule (Minnesota)","volume":"10","author":"Hathaway","year":"1940","journal-title":"Journal of Psychology"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/9780470712184.ch16","article-title":"Chapter 16: Special topics in statistics","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions\u00a0Version 5.0.1 (updated September 2008)","author":"\u00a0Higgins","year":"2008"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0057|cit57","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [updated September 2011]. The Cochrane Collaboration, 2011 Available from www.cochrane-handbook.org."},{"key":"10.1002\/14651858.CD009396.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.63.10.1079","article-title":"Randomized controlled trial of the effect on quality of life of second- vs first-generation antipsychotic drugs in schizophrenia - cost utility of the latest antipsychotic drugs in schizophrenia study (CUtLASS 1)","volume":"63","author":"Jones","year":"2006","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0059|cit59","volume-title":"Positive and Negative Syndrome Scale (PANSS) manual","author":"Kay","year":"1986"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0060|cit60","volume-title":"Diagnosis and Drug Treatment of Psychiatric Disorders","author":"Klein","year":"1969"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0061|cit61","first-page":"1","article-title":"Practice guideline for the treatment of patients with schizophrenia, second edition","volume":"161","author":"Lehman","year":"2004","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.biopsych.2005.10.020","article-title":"Attrition in randomized controlled clinical trials: methodological issues in psychopharmacology","volume":"59","author":"Leon","year":"2006","journal-title":"Biological Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.schres.2005.04.008","article-title":"What does the PANSS mean?","volume":"79","author":"Leucht","year":"2005","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0064|cit64","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1192\/bjp.187.4.366","article-title":"Clinical implications of brief psychiatric rating scale scores","volume":"187","author":"Leucht","year":"2005","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(08)61764-X","article-title":"A meta-analysis comparing second-generation and first-generation antipsychotics for schizophrenia","volume":"373","author":"Leucht","year":"2009","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0067|cit67","unstructured":"Lohse MJ Lorenzen A M\u00fcller-Oerlinghausen B Psychotropic drugs Arzneimittel Verordnungs Report 2005 820 64"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1192\/bjp.176.3.249","article-title":"Unpublished rating scales: a major source of bias in randomised controlled trials of treatments for schizophrenia","volume":"176","author":"Marshall","year":"2000","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0069|cit69","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00127-004-0762-4","article-title":"Schizophrenia and employment ? a review","volume":"39","author":"Marwaha","year":"2004","journal-title":"Social Psychiatry and Psychiatric Epidemiology"},{"issue":"c332","key":"10.1002\/14651858.CD009396.pub2-BIB0070|cit70","first-page":"698","article-title":"CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"3","key":"10.1002\/14651858.CD009396.pub2-BIB0072|cit72","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001949.pub2","article-title":"Pimozide for schizophrenia or related psychoses","author":"Rathbone","year":"2007","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/9780470712184.ch12","article-title":"Chapter 12: Interpreting results and drawing conclusions","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Sch\u00fcnemann","year":"2008"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0074|cit74","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1126\/science.1145194","article-title":"Antipsychotic drugs: direct correlation between clinical potency and presynaptic action on dopamine neurons","volume":"188","author":"Seeman","year":"1975","journal-title":"Science"},{"issue":"8","key":"10.1002\/14651858.CD009396.pub2-BIB0075|cit75","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009227","article-title":"Flupenthixol versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009396.pub2-BIB0076|cit76","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009230","article-title":"Fluphenazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8","key":"10.1002\/14651858.CD009396.pub2-BIB0077|cit77","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009268","article-title":"Haloperidol versus low-potency first-generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"10","key":"10.1002\/14651858.CD009396.pub2-BIB0078|cit78","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD009369","article-title":"Perphenazine versus low-potency first generation antipsychotic drugs for schizophrenia","author":"Tardy","year":"2011","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"11","key":"10.1002\/14651858.CD009396.pub2-BIB0079|cit79","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/j.jclinepi.2004.02.018","article-title":"Effect sizes in cumulative meta-analyses of mental health randomized trials evolved over time","volume":"57","author":"Trikalinos","year":"2004","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0080|cit80","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/archpsyc.1978.01770260031002","article-title":"Suicide in schizophrenics, manics, depressives, and surgical controls: a comparison with general population suicide mortality","volume":"35","author":"Tsuang","year":"1978","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD009396.pub2-BIB0081|cit81","doi-asserted-by":"crossref","first-page":"862\u201375","DOI":"10.1192\/bjp.107.450.862","article-title":"A simple and reliable subclassification of chronic schizophrenia","volume":"107","author":"Wing","year":"1961","journal-title":"Journal of Mental Science"},{"issue":"7","key":"10.1002\/14651858.CD009396.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1192\/pb.bp.108.021949","article-title":"Loss to outcomes stakeholder survey: the LOSS study","volume":"33","author":"Xia","year":"2009","journal-title":"Psychiatric Bulletin"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD009396.pub2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T17:42:22Z","timestamp":1720287742000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD009396.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Schizophrenia Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,7,8]]},"references-count":82,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2014,7]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd009396.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,8]]}}}